DPDP Consulting for Pharma Companies
Get a practical DPDP roadmap for pharma data across trials, PSPs, health records, CROs and marketing consent.
Discuss this page with an LLM
Now replace the sandwich shop with your Pharma company. Where does personal data enter? Where does it sit? Who else touches it?
Pharma DPDP Self-Check
Start here to understand why DPDP is relevant to Pharma. Before any other task, first understand how personal data moves through the business.
What is Pharma?
In this context, Pharma means the websites, apps, operations, support teams, customer records, employee systems, vendor tools and data workflows that collect or use personal data.
Children's data
- Do you collect age, class, school, parent details or learning progress?
- Can you separate child, parent and guardian data?
- Do you know which users are under 18?
Consent
- Can you prove where consent came from?
- Is consent collected before data is used for the stated purpose?
- Can consent be withdrawn without breaking the entire account flow?
Tracking and profiling
- Do you track usage, performance, attention, behavior or drop-offs?
- Is any of this used for ads, recommendations or nudges?
- Are analytics tools collecting user identifiers?
Vendors and SDKs
- Which CRMs, email tools, payment tools, analytics tools and support tools receive personal data?
- Do contracts say they process data only on your instructions?
- Can you delete or export data from each vendor?
Retention
- What happens when the service ends?
- What happens when a user leaves?
- What data is kept for certificates, invoices, disputes or regulatory records?
First action
- Map one user journey from sign-up to completion.
- Mark where data is collected, stored, shared, used for communication and deleted.
If this self-check exposed more than three unclear answers, the next useful step is a DPDP data journey map.
Book a DPDP clarity callFrequently asked questions
Does DPDP apply to patient data collected before the law started?
Yes, you must send a notice to these existing patients. You need to inform them about the data you hold and their right to withdraw consent, even for ongoing longitudinal studies.
Can we share doctor prescribing patterns with third-party marketing firms?
Only if you provide a clear notice to the doctor and obtain specific consent. DPDP classifies this as profiling, which requires transparency about how the data influences your marketing decisions.
Is pharmacovigilance data exempt from consent?
DPDP allows processing for "legitimate uses" like public health. However, you must still provide notice to the individual and ensure the data is not repurposed for marketing without separate consent.